Lynq, a 24/7 institutional settlement network, and The Better Money Company (TBMC), a stablecoin clearinghouse, successfully completed a live proof-of-concept converting client assets into Ripple's USD stablecoin RLUSD within minutes. This test demonstrated the efficiency of Lynq's pre-funded workflow and TBMC's clearinghouse model, aiming to improve liquidity and settlement speed for institutional digital asset transfers. The collaboration is part of a broader effort to rebuild institutional settlement infrastructure after 2023 banking closures, with future phases expected to expand stablecoin options and partner networks.
The live test of Lynq and The Better Money Company converting client assets to RLUSD offers context for digital asset markets. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Oct 13, 2026 20:51 WIB: out of 50 major cryptocurrencies, 7 rose and 42 fell. Notable movers include BAT at Rp3.237 with a 21.87% increase and BAL at Rp16.297 with an 11.14% rise, while ONE dropped 9.13% to Rp31.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
